Samlyn Capital, LLC Vertex Pharmaceuticals Inc Transaction History

Samlyn Capital, LLC

4 transactions

Quarter	Operation	Price Per share	shares change	shares Held
Q3 2018 Nov 14, 2018	SELL	$167.73 - $192.74 $20 Million - $22.9 Million	-118,998 Closed	0 $0
Q2 2018 Aug 14, 2018	SELL	$145.72 - $169.96 $2.39 Million - $2.79 Million	-16,405 Reduced 12.12%	118,998 $20.2 Million
Q1 2018 May 15, 2018	SELL	$151.6 - $177.13 $6.18 Million - $7.22 Million	-40,760 Reduced 23.14%	135,403 $22.1 Million
Q4 2017 Feb 14, 2018	BUY	$137.28 - $155.55 $24.2 Million - $27.4 Million	176,163	176,163 $26.4 Million

1,724

222M

1.58M

1.36M

Ticker VRTX
Exchange NASDAQ
Sector Healthcare
Industry Biotechnology
Shares Outstandng 256,691,008
Market Cap $119B
Description
Vertex Pharmaceuticals Incorporated, a biotechnology company, engages in developing and commercializing therapies for treating cystic fibrosis. The company markets SYMDEKO/SYMKEVI, ORKAMBI, and KALYDECO to treat patients with cystic fibrosis who have specific mutations in their cystic fibrosis transmembrane conductance regulator gene; and TRIKAF...

Get notified when there are updates to the investment portfolio of Samlyn Capital, LLC, based on Form 13F filings with the SEC.

Stay updated on Samlyn Capital, LLC with notifications on news.